loading
Drugs Made In America Acquisition Corp stock is traded at $10.01, with a volume of 908. It is up +0.20% in the last 24 hours and up +0.00% over the past month. Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$9.99
Open:
$10.01
24h Volume:
908
Relative Volume:
0.02
Market Cap:
$304.27M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.10%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$10.01
$10.01
1-Week Range:
Value
$9.98
$10.04
52-Week Range:
Value
$9.96
$10.04

Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile

Name
Name
Drugs Made In America Acquisition Corp
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
DMAA's Discussions on Twitter

Compare DMAA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Shell Companies icon
DMAA
Drugs Made In America Acquisition Corp
10.01 304.27M 0 0 0 0.00
Shell Companies icon
LION
Lionsgate Studios Corp
7.68 2.18B 3.13B 50.80M 555.00M 0.1772
Shell Companies icon
AACT
Ares Acquisition Corporation Ii
11.20 697.50M 0 16.92M -1.35M 0.29
Shell Companies icon
ANSC
Agriculture Natural Solutions Acquisition Corp
10.62 457.99M 0 1.30M 0 0.0301
Shell Companies icon
AAM
Aa Mission Acquisition Corp
10.22 449.41M 0 0 0 0.00
Shell Companies icon
EQV
Eqv Ventures Acquisition Corp
10.04 447.95M 0 0 0 0.00

Drugs Made In America Acquisition Corp Stock (DMAA) Latest News

pulisher
Mar 07, 2025

7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money

Mar 07, 2025
pulisher
Mar 07, 2025

Layoff Tracker: Atea Pharmaceuticals Cuts 25% of Workforce - BioSpace

Mar 07, 2025
pulisher
Mar 03, 2025

Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World

Mar 03, 2025
pulisher
Feb 26, 2025

Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company - Investors | Eli Lilly and Company

Feb 26, 2025
pulisher
Feb 24, 2025

Drugs Made in America Acquisition Corp. Announces Advisory Team - GlobeNewswire

Feb 24, 2025
pulisher
Feb 22, 2025

Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet

Feb 22, 2025
pulisher
Feb 21, 2025

Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025 - The Manila Times

Feb 21, 2025
pulisher
Feb 20, 2025

Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025 - Marketscreener.com

Feb 20, 2025
pulisher
Feb 18, 2025

Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - TradingView

Feb 18, 2025
pulisher
Feb 18, 2025

Drugs Made In America Acquisition Announces Closing Of Full Exercise Of IPO Over-Allotment Option - Marketscreener.com

Feb 18, 2025
pulisher
Feb 12, 2025

Drugs Made In America Acquisition Corp.’s $200 Million Initial Public Offering - Global Legal Chronicle

Feb 12, 2025
pulisher
Feb 07, 2025

Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma - FiercePharma

Feb 07, 2025
pulisher
Feb 06, 2025

United Parcel Service (UPS) | History, Services, & Facts - Britannica

Feb 06, 2025
pulisher
Jan 30, 2025

Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering - The Manila Times

Jan 30, 2025
pulisher
Jan 28, 2025

Drugs Made In America Acquisition Prices $200 Million IPO -January 28, 2025 at 04:53 am EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 27, 2025

Drugs Made in America Acquisition Corp. (DMAAU) Prices $200M IPO - SPACInsider

Jan 27, 2025
pulisher
Jan 27, 2025

New Pharma SPAC Launches With $200M War Chest: Inside The Latest Healthcare IPO - StockTitan

Jan 27, 2025
pulisher
Jan 14, 2025

Drugmakers hiked prices for hundreds of drugs in early January - NPR

Jan 14, 2025
pulisher
Jan 13, 2025

The top 10 biopharma M&A deals of 2024 - FiercePharma

Jan 13, 2025
pulisher
Jan 02, 2025

2024 drug approvals: Small companies loom large with several key FDA nods - FiercePharma

Jan 02, 2025
pulisher
Dec 28, 2024

Bright Green enters into restructuring security agreement with Lynn Stockwell - Yahoo Finance

Dec 28, 2024
pulisher
Dec 27, 2024

Bright Green (BGXX) Announces Major Restructuring: Founder Returns as CEO, Plans API Manufacturing Focus - StockTitan

Dec 27, 2024
pulisher
Dec 05, 2024

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin - FiercePharma

Dec 05, 2024
pulisher
Nov 22, 2024

7 Companies Owned by Pfizer - Investopedia

Nov 22, 2024
pulisher
Oct 21, 2024

Top 10 Asthma Drug Companies | Provides Best MedicinesMarket.us Media - Market.us Media - United States Market News

Oct 21, 2024
pulisher
Oct 18, 2024

FTC’s watchdog role in pharma mergers: Road bumps and the way forward - Norton Rose Fulbright

Oct 18, 2024
pulisher
Oct 14, 2024

IPO Roundup: Drugs Made in America Acquisition, FBS Global and more (NYSEARCA:IPO) - Seeking Alpha

Oct 14, 2024
pulisher
Oct 04, 2024

BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda - FiercePharma

Oct 04, 2024
pulisher
Oct 01, 2024

23andMe Is Sinking Fast. Can the Company Survive? - WIRED

Oct 01, 2024
pulisher
Sep 03, 2024

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements - GlobeNewswire

Sep 03, 2024
pulisher
Aug 12, 2024

FTC v Actavis and pricing practices spearhead rise in US pharmaceutical antitrust cases - Global Competition Review

Aug 12, 2024
pulisher
Jul 25, 2024

We bought what’s needed to make millions of fentanyl pills–for $3,600 - Reuters.com

Jul 25, 2024
pulisher
Jul 10, 2024

Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market - BioSpace

Jul 10, 2024
pulisher
Jul 04, 2024

Semnur Pharmaceuticals to go public in $2bn SPAC deal - Pharmaceutical Technology

Jul 04, 2024
pulisher
Jul 02, 2024

China-made injectable PD-L1 drug flunks pivotal trial, forcing US partner to seek strategic options - FiercePharma

Jul 02, 2024
pulisher
Jun 24, 2024

Top 10 smartest deals in biopharma - Fierce Biotech

Jun 24, 2024
pulisher
May 14, 2024

Artificial Intelligence in Genomics Market Size US$ 16,431.16 Million by 2033 - BioSpace

May 14, 2024
pulisher
May 02, 2024

Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages - ABC News

May 02, 2024
pulisher
Apr 15, 2024

Chinese Company Under Congressional Scrutiny Makes Key U.S. Drugs - The New York Times

Apr 15, 2024
pulisher
Apr 06, 2024

Initial Public Offering (IPO) News Live Feed - StockTitan

Apr 06, 2024
pulisher
Apr 05, 2024

Eli Lilly and Company - Britannica

Apr 05, 2024
pulisher
Apr 04, 2024

Pfizer Inc. - Britannica

Apr 04, 2024
pulisher
Mar 13, 2024

Bright Green invests $250m to expand facility in New Mexico - Pharmaceutical Technology

Mar 13, 2024
pulisher
Mar 11, 2024

The top 10 drugs losing US exclusivity in 2024 - FiercePharma

Mar 11, 2024
pulisher
Mar 10, 2024

Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know - CNBC

Mar 10, 2024
pulisher
Mar 05, 2024

Novartis, Ono Latest to Announce Billion-Dollar M&A Deals - BioSpace

Mar 05, 2024
pulisher
Feb 27, 2024

US launches antitrust investigation into UnitedHealth, WSJ reports - Reuters.com

Feb 27, 2024
pulisher
Feb 14, 2024

Senate Report Exposes Big Pharma's Profiteering at Americans’ Expense - TechTarget

Feb 14, 2024
pulisher
Jan 31, 2024

Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma

Jan 31, 2024
pulisher
Jan 29, 2024

Obamacare Created Big Medicine - The Lever

Jan 29, 2024
pulisher
Jan 25, 2024

Bright Green Corporation announces the agreement to acquire - GlobeNewswire

Jan 25, 2024

Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data

There is no financial data for Drugs Made In America Acquisition Corp (DMAA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$11.61
price up icon 0.09%
shell_companies ALF
$10.23
price up icon 0.39%
$0.00
price up icon 0.39%
$10.57
price up icon 0.09%
$0.00
price up icon 0.05%
shell_companies EQV
$10.04
price down icon 0.10%
Cap:     |  Volume (24h):